Insulin-autoreactive CD4+ T cells have also been described in T1D patients, and there is evidence suggesting that high-avidity insulin-reactive thymocytes may evade central tolerance in such patients [7]. This evidence concerns the gene CD4 and type 1 diabetes mellitus.